BioCentury Publications Inc.

2009 Mid-Atlantic Bio Conference Attracts Record Number of Bioscience Companies.(Conference news)
Chemicals & Chemistry Business; 11/27/2009; 1038 words; ...regulatory changes will impact the future of the bioscience industry, while Steve Usdin, Senior Editor, BioCentury Publications, Inc. provided an update to the progress of the healthcare debate. Additionally, Representative Bob Goodlatte...

Howard Dean to Speak at the 2009 Mid-Atlantic Bio Conference.(Conference news)
Biotech Week; 11/11/2009; 1055 words; ...Eshoo, (D-Calif.), and Tony Zook, CEO of AstraZeneca North America. Steve Usdin, Senior Editor, BioCentury Publications, Inc., will moderate the panel. Representative Bob Goodlatte (R-Va.) will make remarks at the "CEO &...

Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009.(Company rankings)
Business Wire; 9/22/2009; 1490 words; ...GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Merck Serono, Novartis, Pfizer, Roche, Sanofi...Europe, the investor conference co-organized with BioCentury Publications and BIO * ChinaBio([R]) Partnering Forum, the...

Profiles Vivakor, Inc. & Cleveland BioLabs, Inc.
M2 Presswire; 9/8/2009; 1078 words; ...Cleveland BioLabs, Inc. closed at $3.75...Conference Cleveland BioLabs, Inc. (NASDAQ: CBLI) earlier...Conference, presented by BioCentury and Thomson Reuters...About Cleveland BioLabs, Inc. Cleveland BioLabs...Trader, Market News Publications, AFX U.K., Future...

San Francisco Welcomes BioPharm America[TM] and ChinaBio[R] Day.
Business Wire; 7/28/2009; 1051 words; ...Gilead, Johnson & Johnson, Merck & Co., Inc., Pfizer, Takeda and UCB. With a special emphasis...Europe, the investor conference co-organized with BioCentury Publications and BIO * ChinaBio[R] Partnering Forum, the first...